Standout Papers

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or ... 2016 2026 2019 2022 321
  1. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence (2016)
    Fred Poordad, Eugene R. Schiff et al. Hepatology

Immediate Impact

30 by Nobel laureates 65 from Science/Nature 86 standout
Sub-graph 1 of 18

Citing Papers

A guide to antigen processing and presentation
2022 Standout
Hepatitis C
2019 Standout
33 intermediate papers

Works of Eric Hughes being referenced

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
2016 Standout
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C
2013
and 10 more

Author Peers

Author Last Decade Papers Cites
Eric Hughes 1802 1654 569 653 62 2.9k
Fritz von Weizsäcker 1692 1833 442 708 63 3.1k
Artur Kaul 2004 1631 561 369 34 3.0k
Soon B. Hwang 1812 1393 285 495 80 2.8k
Nobuhiko Hiraga 2157 2108 387 357 88 3.0k
Mina Nakagawa 1506 1223 269 478 73 2.3k
Ranjit Ray 1335 1383 236 497 46 2.6k
Zongyi Hu 1869 1490 419 515 59 3.5k
Ranjit Ray 2310 1908 504 689 71 3.6k
Chunfu Wang 2974 2391 944 889 53 4.0k
Hidenori Ochi 2281 2620 351 382 119 4.1k

All Works

Loading papers...

Rankless by CCL
2026